» Articles » PMID: 25999658

Analysis of Serum MicroRNAs As Potential Biomarker in Coronary Bifurcation Lesion

Overview
Journal Dis Markers
Publisher Wiley
Specialty Biochemistry
Date 2015 May 23
PMID 25999658
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence suggests that cell-derived circulating miRNAs may serve as the biomarkers of cardiovascular diseases. However, no study has investigated the potential of circulating miRNAs as biomarker for coronary bifurcation lesion. In this study, we aimed to characterize the miRNA profiles that could distinguish coronary bifurcation lesion and identify potential miRNAs as biomarkers of coronary bifurcation lesion. We employed miRNA microarray to screen serum miRNAs profiles of patients with coronary bifurcation lesion and coronary nonbifurcation lesions. We identified 197 miRNAs differentially expressed, including 150 miRNAs upregulated and 47 miRNAs downregulated. We chose 3 miRNAs with significant differences for further testing in 200 patients. RT-PCR analysis of serum samples confirmed that miR30d was upregulated and miR1246 was downregulated in the serum of coronary bifurcation lesion patients compared with nonbifurcation lesion patients. Our findings suggest that these miRNAs may have a role in the pathogenesis of coronary bifurcation lesion and may represent novel biomarkers for the diagnosis and prognosis of coronary bifurcation lesion.

Citing Articles

Downregulation of circulating miR-320a and target gene prediction in patients with diabetic retinopathy.

Prado M, de Jesus M, de Goes T, Mendonca L, Kaneto C BMC Res Notes. 2020; 13(1):155.

PMID: 32178730 PMC: 7077016. DOI: 10.1186/s13104-020-05001-9.


Identification of miR-328-3p as an endogenous reference gene for the normalization of miRNA expression data from patients with Diabetic Retinopathy.

Prado M, de Goes T, de Jesus M, Mendonca L, Nascimento J, Kaneto C Sci Rep. 2019; 9(1):19677.

PMID: 31873160 PMC: 6928074. DOI: 10.1038/s41598-019-56172-w.


Circulating microRNAs as possible biomarkers for coronary artery disease: a narrative review.

Melak T, Baynes H EJIFCC. 2019; 30(2):179-194.

PMID: 31263392 PMC: 6599194.


High-throughput approaches for screening and analysis of cell behaviors.

Seo J, Shin J, Leijten J, Jeon O, Camci-Unal G, Dikina A Biomaterials. 2017; 153:85-101.

PMID: 29079207 PMC: 5702937. DOI: 10.1016/j.biomaterials.2017.06.022.


Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.

Abu-Halima M, Meese E, Keller A, Abdul-Khaliq H, Radle-Hurst T J Transl Med. 2017; 15(1):156.

PMID: 28693530 PMC: 5504636. DOI: 10.1186/s12967-017-1255-z.

References
1.
Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y . Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013; 108(3):644-52. PMC: 3593570. DOI: 10.1038/bjc.2013.8. View

2.
Fichtlscherer S, Zeiher A, Dimmeler S . Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?. Arterioscler Thromb Vasc Biol. 2011; 31(11):2383-90. DOI: 10.1161/ATVBAHA.111.226696. View

3.
Eisen M, Spellman P, Brown P, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A. 1998; 95(25):14863-8. PMC: 24541. DOI: 10.1073/pnas.95.25.14863. View

4.
Frangos C, Noble S, Piazza N, Asgar A, Fortier A, Ly Q . Impact of bifurcation lesions on angiographic characteristics and procedural success in primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Arch Cardiovasc Dis. 2011; 104(4):234-41. DOI: 10.1016/j.acvd.2011.02.001. View

5.
Hoekstra M, van der Lans C, Halvorsen B, Gullestad L, Kuiper J, Aukrust P . The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun. 2010; 394(3):792-7. DOI: 10.1016/j.bbrc.2010.03.075. View